Stock Scorer

BioCorRx Inc. (BICX)

BioCorRx Inc. reported revenue of 88K USD for the quarter ending 30 June 2026, down 34.8% from 134.9K a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 88K -34.8%
Gross Profit Q3 '14 · ending 30 September 2014 349.7K -18.6%
Operating Income Q2 '26 · ending 30 June 2026 -1.5M —
Net Income Q2 '26 · ending 30 June 2026 -964.8K —
Cost of Revenue Q2 '26 · ending 30 June 2026 145K —
Operating Cash Flow Q2 '26 · ending 30 June 2026 -440.3K —
Free Cash Flow Q4 '19 · ending 31 December 2019 -944.1K —
Shares Outstanding Q2 '26 · ending 30 June 2026 29.2M +93.6%
EPS Q2 '26 · ending 30 June 2026 -0.12 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 797.2K-4.8M-3.4M—
20242024-12-31 7.7K-5.1M-5.1M—
20232023-12-31 89.2K-3.8M-3.8M—
20222022-12-31 213.8K-4.7M-4.4M-2M
20212021-12-31 48.3K-5.5M-5.2M-3.5M
20202020-12-31 122.6K-7.5M-3.5M-2.2M
20192019-12-31 240.3K-5.6M-6M-3.1M
20182018-12-31 376.7K-4.6M-6.6M-1.8M
20172017-12-31 657.3K-2.9M-29.7M-2.5M
20162016-12-31 701.8K-2.2M-5.9M-2.3M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-3088K
Q1 '262026-03-31214.5K
Q3 '252025-09-30635.2K
Q2 '252025-06-30178.2K
Q1 '252025-03-31134.9K
Q4 '242024-12-310
Q3 '242024-09-300
Q2 '242024-06-304K
Q1 '242024-03-313.6K
Q4 '232023-12-3118.9K
Q3 '232023-09-3010.1K
Q2 '232023-06-3019.6K
Q1 '232023-03-3140.4K
Q4 '222022-12-3182.9K
Q3 '222022-09-3094.4K
Q2 '222022-06-3016K
Q1 '222022-03-3120.5K
Q4 '212021-12-3113.6K
Q3 '212021-09-308.8K
Q2 '212021-06-3015.7K

Gross Profit Quarterly

PeriodEndingGross Profit
Q3 '142014-09-30349.7K
Q2 '142014-06-30190.7K
Q1 '142014-03-31103.1K
Q3 '132013-09-30277.4K
Q2 '132013-06-30429.7K
Q1 '132013-03-31308.1K
Q4 '122012-12-31329K
Q3 '122012-09-30-19.9K
Q2 '122012-06-3055K
Q1 '122012-03-31101.5K
Q4 '112011-12-316.5K
Q3 '112011-09-30197.5K
Q2 '112011-06-30176.5K
Q1 '112011-03-31-9.3K

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-1.5M
Q1 '262026-03-31-956K
Q4 '252025-12-31-534.2K
Q3 '252025-09-30-1.9M
Q2 '252025-06-30-1.4M
Q1 '252025-03-31-937.9K
Q4 '242024-12-31-1.1M
Q3 '242024-09-30-1.7M
Q2 '242024-06-30-1.4M
Q1 '242024-03-31-968.7K
Q4 '232023-12-31-822.7K
Q3 '232023-09-30-961.9K
Q2 '232023-06-30-946.9K
Q1 '232023-03-31-1.1M
Q4 '222022-12-31-1.2M
Q3 '222022-09-30-1M
Q2 '222022-06-30-1.4M
Q1 '222022-03-31-1.1M
Q4 '212021-12-31-1.3M
Q3 '212021-09-30-1.6M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-964.8K
Q1 '262026-03-31-831.2K
Q4 '252025-12-31-471.2K
Q3 '252025-09-30-1.9M
Q2 '252025-06-30-1.2M
Q1 '252025-03-31-841.4K
Q4 '242024-12-31-1.2M
Q3 '242024-09-30-1.5M
Q2 '242024-06-30-1.2M
Q1 '242024-03-31-1.2M
Q4 '232023-12-31-969K
Q3 '232023-09-30-867.3K
Q2 '232023-06-30-923.5K
Q1 '232023-03-31-1M
Q4 '222022-12-31-1.2M
Q3 '222022-09-30-951K
Q2 '222022-06-30-1.3M
Q1 '222022-03-31-945K
Q4 '212021-12-31-1.2M
Q3 '212021-09-30-1.4M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-30145K
Q1 '262026-03-3125.2K
Q2 '252025-06-300
Q1 '252025-03-310
Q4 '242024-12-310
Q3 '242024-09-300
Q2 '242024-06-300
Q1 '242024-03-311.7K
Q4 '232023-12-3113.1K
Q3 '232023-09-303.9K
Q2 '232023-06-3010.4K
Q1 '232023-03-318.7K
Q4 '222022-12-318.7K
Q3 '222022-09-302.3K
Q2 '222022-06-302.7K
Q1 '222022-03-311.5K
Q4 '212021-12-312.4K
Q3 '212021-09-301K
Q2 '212021-06-301.8K
Q1 '212021-03-31632

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-440.3K
Q1 '262026-03-31-433K
Q4 '252025-12-31-847.7K
Q3 '252025-09-30-634.4K
Q2 '252025-06-30-126.5K
Q1 '252025-03-31-689.6K
Q4 '242024-12-31-247.2K
Q3 '242024-09-30-357.5K
Q2 '242024-06-30-151.9K
Q1 '242024-03-31-339.7K
Q4 '232023-12-31-533.8K
Q3 '232023-09-30-350.5K
Q2 '232023-06-30-571.5K
Q1 '232023-03-31-397.4K
Q4 '222022-12-31-449.6K
Q3 '222022-09-30-367.8K
Q2 '222022-06-30-351.7K
Q1 '222022-03-31-872.7K
Q4 '212021-12-31-647.6K
Q3 '212021-09-30-621.7K

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q4 '192019-12-31-944.1K
Q3 '192019-09-30-958.8K
Q2 '192019-06-30-1M
Q1 '192019-03-31-361K
Q4 '182018-12-31-440.4K
Q3 '182018-09-30-490.8K
Q4 '162016-12-31-505.8K
Q3 '162016-09-30-732.8K
Q2 '162016-06-30-734.7K
Q1 '162016-03-31-331.7K
Q4 '142014-12-3165.8K
Q3 '142014-09-30-285.5K
Q2 '142014-06-30387.2K
Q1 '142014-03-31-342
Q3 '132013-09-30-39.8K
Q2 '132013-06-30-61K
Q1 '132013-03-31-57.4K

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3029.2M
Q1 '262026-03-3125.6M
Q3 '252025-09-3018.2M
Q2 '252025-06-3017M
Q1 '252025-03-3115.1M
Q3 '242024-09-3010.9M
Q2 '242024-06-309.5M
Q1 '242024-03-312.9M
Q1 '232023-03-311.8M
Q1 '222022-03-311.1M
Q1 '212021-03-311.1M
Q1 '202020-03-311.1M
Q1 '192019-03-312.4M
Q2 '182018-06-30250.5M
Q1 '182018-03-311.8M
Q2 '172017-06-30579.7M
Q1 '172017-03-31355.9M
Q1 '162016-03-3125.5M
Q2 '152015-06-30151.8M
Q1 '152015-03-3119.8M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-0.12
Q1 '262026-03-31-0.16
Q4 '252025-12-31-0.19
Q3 '252025-09-30-0.32
Q2 '252025-06-30-0.35
Q1 '252025-03-31-0.41
Q4 '192019-12-31-1.72
Q3 '192019-09-30-2.61
Q2 '192019-06-30-3.03
Q1 '192019-03-31-2.36
Q4 '182018-12-31-2.10
Q3 '182018-09-30-13.81
Q2 '182018-06-30-13.06
Q1 '182018-03-31-13.04
Q4 '172017-12-31-12.82
Q3 '172017-09-30-0.17
Q2 '172017-06-30-0.19
Q1 '172017-03-31-0.22
Q4 '162016-12-31-0.03
Q3 '162016-09-30-0.03